Similar articles

• Synthetic plasma pool cohort correction for affinity-based proteomics datasets allows multiple study comparison.

  Heylen D, Pusparum M, Kuliesius J, Wilson J, Park YC, Jamiołkowski J, D'Onofrio V, Valkenborg D, Aerts J, Ertaylan G, Hooyberghs J. Heylen D, et al. Brief Bioinform. 2024 Nov 22;26(1):bbae657. doi: 10.1093/bib/bbae657. Brief Bioinform. 2024. PMID: 39694815 Free PMC article.
• Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics.

  Chan MY, Efthymios M, Tan SH, Pickering JW, Troughton R, Pemberton C, Ho HH, Prabath JF, Drum CL, Ling LH, Soo WM, Chai SC, Fong A, Oon YY, Loh JP, Lee CH, Foo RSY, Ackers-Johnson MA, Pilbrow A, Richards AM. Chan MY, et al. Circulation. 2020 Oct 13;142(15):1408-1421. doi: 10.1161/CIRCULATIONAHA.119.045158. Epub 2020 Sep 4. Circulation. 2020. PMID: 32885678 Free PMC article. Clinical Trial.
• pseudoQC: A Regression-Based Simulation Software for Correction and Normalization of Complex Metabolomics and Proteomics Datasets.

  Wang S, Yang H. Wang S, et al. Proteomics. 2019 Oct;19(19):e1900264. doi: 10.1002/pmic.201900264. Epub 2019 Sep 18. Proteomics. 2019. PMID: 31474000
• Affinity prefractionation for MS-based plasma proteomics.

  Pernemalm M, Lewensohn R, Lehtiö J. Pernemalm M, et al. Proteomics. 2009 Mar;9(6):1420-7. doi: 10.1002/pmic.200800377. Proteomics. 2009. PMID: 19235168 Review.
• Advances and applications of de novo designed affinity ligands in proteomics.

  Roque AC, Lowe CR. Roque AC, et al. Biotechnol Adv. 2006 Jan-Feb;24(1):17-26. doi: 10.1016/j.biotechadv.2005.05.001. Epub 2005 Jul 11. Biotechnol Adv. 2006. PMID: 16006085 Review.